Evaxion Biotech (EVAX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Evaxion Biotech (EVAX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Evaxion Biotech

· EVAX

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

27.956 M

+2.19%

General

Market Cap: $27.36M
Enterprise Value: $13.82M
Shares Outstanding: 417,010,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 100.00%
Operating Margin: -115.98%
Net Profit Margin: -115.49%
FCF Margin: —
ROA: -44.65%
ROE: -61.39%
ROIC: -46.68%
Current Ratio: 5.06
Debt-to-Equity: 0.75
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 2.77
P/FCF: —
P/B: 2.17
EV/EBITDA: -1.39

Growth

Rev 1Y: —
Rev 1Y Fwd Est: 109.88%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —

Income Statement (TTM)

Revenue: $7.49M
Gross Margin: 100.00%
Operating Expenses: $16.18M
Operating Income: -$8.69M
Net Profit: -$8.65M

Balance Sheet

EPS 10Y (CAGR)

—

Cash and Equivalents: $14M
Working Capital: $12.72M
Total Assets: $19.38M
Net Debt: -$6.89M
Total Liabilities: $9.85M
Total Equity: $9.53M

Cash Flow Statement (TTM)

Cash Flow from Operations: —
Cash Flow from Investing: —
Cash Flow from Financing: —
Free Cash Flow: —
Capital Expenditures: —